PRDM9によって調節されるACTN2は,頭蓋内動脈瘤のPDLIM1と相互作用することによって,血管の滑らかな筋肉細胞の成長と炎症に影響する
Guangxu Zhang1, Jinbing Zhao1, Zhiqiang Yu1
1Department of Neurosurgery, Affiliated Nanjing Brain Hospital, Nanjing Medical University, Nanjing, China.
Frontiers in molecular neuroscience
|August 29, 2025
まとめ
この研究では,PRDM9がACTN2を表遺伝的に制御し,血管の滑らかな筋肉細胞機能と動脈瘤の進行に影響を及ぼすことが明らかになりました. PRDM9-ACTN2-PDLIM1軸は,動脈瘤の治療のための新しいターゲットを提供します.
科学分野:
- 血管生物学
- 分子遺伝学
- エピジェネティクス
背景:
- 動脈瘤は,血管の滑らかな筋肉細胞 (VSMC) の成長と炎症に関連しています.
- 頭蓋内動脈瘤 (IA) に関するACTN2の正確な役割は不明である.
- VSMCの調節を理解することは,動脈瘤の病原性にとって極めて重要です.
研究 の 目的:
- 動脈瘤の進行におけるPRDM9-ACTN2-PDLIM1軸の解明
- この軸がVSMCの行動に与える影響を調査する.
- 動脈瘤の新たな治療標的を特定する
主な方法:
- GEOデータセット (GSE54083,GSE75436) とPPIネットワークのバイオ情報分析
- shRNA/過剰発現,免疫光,ELISA,ウェスタンブラットを用いたインビトロ試験.
- ChIP-qPCRとCRISPR-Cas9を用いて表遺伝子と遺伝子検証を行う.
- PDLIM1の役割を確認する 機能的な救出実験
主要な成果:
- ACTN2はIA組織でダウン調節され,VSMCアポトーシスと炎症をヒッポ経路阻害によって悪化させた.
- PRDM9はH3K4me3によるACTN2転写を促進し,低PRDM9発現はACTN2を抑制した.
- PDLIM1はACTN2と相互作用し,その過剰発現はHippo- YAP経路を通じてACTN2のノックダウン効果を逆転させた.
結論:
- PRDM9はACTN2を表遺伝的に調節し,VSMCの機能と動脈瘤の進行に影響を与えます.
- PRDM9-ACTN2-PDLIM1軸は動脈瘤の発達における重要な媒介体である.
- この軸は,臨床動脈瘤の介入のための潜在的な理論的基礎を提供します.
関連する概念動画
Regulation of Angiogenesis and Blood Supply
2.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
TGF - β Signaling Pathway
7.6K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.6K
PI3K/mTOR/AKT Signaling Pathway
3.9K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.9K
Nitric Oxide Signaling Pathway
5.2K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.2K
Notch Signaling Pathway
4.4K
The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.4K


